The quadrupole filters or focuses selected ions before they enter the Orbitrap analyzer. This front-end selection helps control which mass-to-charge ratio signals proceed to the trapping region, making the subsequent measurement more targeted. In complex medical samples, that staged ion handling supports precise analysis of molecules present alongside many other chemical components.
After ions enter the Orbitrap, electrostatic fields trap them and produce oscillatory motion. That motion generates an image current, an electrical signal associated with the trapped ions. The instrument applies Fourier-transform analysis to the signal, converting the measured oscillations into a mass spectrum that represents the ions according to their mass-to-charge ratios.
Accurate mass measurements and high resolving power strengthen molecular identification when samples contain many components. They help distinguish and characterize signals according to precise mass-to-charge values rather than relying only on broad or overlapping measurements. This capability is especially relevant when medical studies examine proteins, metabolites, lipids, pharmaceuticals, or biomarkers in complex samples.
The measurement proceeds through linked stages: the quadrupole first filters or focuses selected ions, those ions then enter the Orbitrap, electrostatic fields trap them, and their oscillations produce an image current. Fourier-transform processing converts that current into a mass spectrum. The resulting spectrum supports precise molecular analysis based on mass-to-charge measurements.
In medicine, this approach is useful for clinical research, drug development, pharmacokinetic studies, and investigations of disease-associated molecular changes. Its combination of sensitive analysis, accurate mass measurement, and resolving power allows researchers to examine molecular patterns in complex samples and connect measured compounds with pharmaceutical, physiological, or disease-related research questions.
The platform supports analysis of several medically important molecular categories, including proteins, metabolites, lipids, pharmaceuticals, and biomarkers. Examining these different targets allows studies to address varied questions, from characterizing molecular constituents to tracking drug-related measurements or investigating changes associated with disease. The appropriate target depends on the research objective and sample context.